(Allergan plc)

	AGN latest price $155.7742 (0.88%) ($153.7251 - $155.8936) on Fri. Nov. 30, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.72% (three month average)
RSI	29
Latest Price	$155.7742(0.88%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.4% a day on average for past five trading days.
Weekly Trend	AGN declines -2.2% a week on average for past two weeks.
Market Behavior	Broad based rally for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    ARKG(47%)    XBI(47%)    XLV(47%)    IVE(45%)
Factors Impacting AGN price	AGN will decline at least -0.86% in a week (0% probabilities).   VIXM(-26%)    TLT(-24%)    UUP(-19%)    DIA(-17%)    VXX(-15%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.86% (StdDev 1.72%)
Hourly BBV	0 ()
Intraday Trend	0.4%

1 - 5 Day Possible Target	$148.89(-4.42%)
Resistance Level	$158.12
5 Day Moving Average	$153.54(1.46%)
10 Day Moving Average	$153.82(1.27%)
20 Day Moving Average	$158.12(-1.48%)
To recent high	-18.7%
To recent low	3%
Market Cap	$51.359b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed